Načítá se...
Pretargeting CWR22 prostate tumor in mice with MORF-B72.3 antibody and radiolabeled cMORF
PURPOSE: We have now applied our MORF/cMORF pre-targeting technology to the targeting of CWR22 prostate tumor in nude mice. METHODS: The antiTAG-72 antibody B72.3 was conjugated with an 18 mer MORF while the cMORF was radiolabeled with (99m)Tc. The specific binding of the antibody to the CWR22 cells...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2007
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2259287/ https://ncbi.nlm.nih.gov/pubmed/17909792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-007-0606-z |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|